Annelies Verbiest

673 total citations
32 papers, 386 citations indexed

About

Annelies Verbiest is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Annelies Verbiest has authored 32 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 19 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Annelies Verbiest's work include Renal cell carcinoma treatment (25 papers), Renal and related cancers (17 papers) and Cancer Genomics and Diagnostics (5 papers). Annelies Verbiest is often cited by papers focused on Renal cell carcinoma treatment (25 papers), Renal and related cancers (17 papers) and Cancer Genomics and Diagnostics (5 papers). Annelies Verbiest collaborates with scholars based in Belgium, France and United Kingdom. Annelies Verbiest's co-authors include Benoit Beuselinck, Jessica Zucman‐Rossi, Maarten Albersen, Daan Dierickx, Jacques Pirenne, Gabrielle Couchy, Hendrik Van Poppel, Evelyne Lerut, Sylvie Job and Aurélien de Reyniès and has published in prestigious journals such as PLoS ONE, The Journal of Urology and Annals of Oncology.

In The Last Decade

Annelies Verbiest

30 papers receiving 383 citations

Peers

Annelies Verbiest
J.-L. Lee South Korea
Fawaz Almutairi Saudi Arabia
Gilles Quéré France
Butuo Li China
Jian-ying Ma China
Osvaldo Arén Frontera United States
L.L. Siu Canada
Öznur Bal Türkiye
Craig Vargo United States
S.A. Loening Germany
J.-L. Lee South Korea
Annelies Verbiest
Citations per year, relative to Annelies Verbiest Annelies Verbiest (= 1×) peers J.-L. Lee

Countries citing papers authored by Annelies Verbiest

Since Specialization
Citations

This map shows the geographic impact of Annelies Verbiest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annelies Verbiest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annelies Verbiest more than expected).

Fields of papers citing papers by Annelies Verbiest

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annelies Verbiest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annelies Verbiest. The network helps show where Annelies Verbiest may publish in the future.

Co-authorship network of co-authors of Annelies Verbiest

This figure shows the co-authorship network connecting the top 25 collaborators of Annelies Verbiest. A scholar is included among the top collaborators of Annelies Verbiest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annelies Verbiest. Annelies Verbiest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oeste, Clara L., Vincent Geldhof, Lieselot Croes, et al.. (2025). Cardiovascular toxicities in cancer patients treated with immune checkpoint inhibitors: multicenter study using natural language processing on Belgian hospital data. PubMed. 7. 100111–100111. 2 indexed citations
2.
Verbiest, Annelies, Ilkka Ilonen, Michael Franz, et al.. (2025). 1867P FALCON-Lung: Evolving global ICI treatment patterns and outcomes in the era of personalized mNSCLC treatment. Annals of Oncology. 36. S1004–S1004. 1 indexed citations
3.
4.
Kinget, Lisa, Eduard Roussel, Diether Lambrechts, et al.. (2021). MicroRNAs Possibly Involved in the Development of Bone Metastasis in Clear-Cell Renal Cell Carcinoma. Cancers. 13(7). 1554–1554. 11 indexed citations
5.
Kinget, Lisa, Eduard Roussel, Diether Lambrechts, et al.. (2021). 689P Human leukocyte antigen (HLA) class I/II expression as a predictive biomarker for response to immune oncology (IO) therapy in metastatic clear-cell renal cell carcinoma (m-ccRCC). Annals of Oncology. 32. S706–S706. 2 indexed citations
6.
Roussel, Eduard, Annelies Verbiest, Lisa Kinget, et al.. (2021). Molecular Subtypes and Gene Expression Signatures as Prognostic Features in Fully Resected Clear Cell Renal Cell Carcinoma: A Tailored Approach to Adjuvant Trials. Clinical Genitourinary Cancer. 19(6). e382–e394. 8 indexed citations
7.
Roussel, Eduard, Lisa Kinget, Annelies Verbiest, et al.. (2021). C-reactive protein and neutrophil-lymphocyte ratio are prognostic in metastatic clear-cell renal cell carcinoma patients treated with nivolumab. Urologic Oncology Seminars and Original Investigations. 39(4). 239.e17–239.e25. 21 indexed citations
8.
Roussel, Eduard, Lisa Kinget, Annelies Verbiest, et al.. (2021). Molecular underpinnings of glandular tropism in metastatic clear cell renal cell carcinoma: therapeutic implications. Acta Oncologica. 60(11). 1499–1506. 13 indexed citations
9.
Verbiest, Annelies, Vincent van Hoef, Cristina Rodríguez‐Antona, et al.. (2020). MicroRNA expression profiles in molecular subtypes of clear-cell renal cell carcinoma are associated with clinical outcome and repression of specific mRNA targets. PLoS ONE. 15(9). e0238809–e0238809. 5 indexed citations
10.
Verbiest, Annelies, Eduard Roussel, Lorenzo Tosco, et al.. (2020). Long-Term Outcomes in Clear-Cell Renal Cell Carcinoma Patients Treated with Complete Metastasectomy. Lirias (KU Leuven). 4(4). 177–183. 3 indexed citations
11.
Meylan, Maxime, Benoit Beuselinck, Cécile Dalban, et al.. (2020). 700O Kidney ccRCC immune classification (KIC) enhances the predictive value of T effector (Teff) and angiogenesis (Angio) signatures in response to nivolumab (N). Annals of Oncology. 31. S553–S553. 7 indexed citations
12.
Verbiest, Annelies, Evelyne Lerut, Marcella Baldewijns, et al.. (2020). Bone metastasis is associated with poor prognosis in metastatic papillary renal cell carcinoma patients treated with first agent angiogenesis inhibitors. Urologic Oncology Seminars and Original Investigations. 38(8). 686.e1–686.e9. 2 indexed citations
13.
Verbiest, Annelies, Stefano Caruso, Gabrielle Couchy, et al.. (2019). Clear-cell Renal Cell Carcinoma: Molecular Characterization of IMDC Risk Groups and Sarcomatoid Tumors. Clinical Genitourinary Cancer. 17(5). e981–e994. 27 indexed citations
14.
Verbiest, Annelies, Diether Lambrechts, Thomas Van Brussel, et al.. (2018). Polymorphisms in the Von Hippel–Lindau Gene Are Associated With Overall Survival in Metastatic Clear-Cell Renal-Cell Carcinoma Patients Treated With VEGFR Tyrosine Kinase Inhibitors. Clinical Genitourinary Cancer. 16(4). 266–273. 8 indexed citations
15.
Verbiest, Annelies, Gabrielle Couchy, Sylvie Job, et al.. (2018). Molecular Subtypes of Clear-cell Renal Cell Carcinoma are Prognostic for Outcome After Complete Metastasectomy. European Urology. 74(4). 474–480. 41 indexed citations
16.
Vanmechelen, Maxime, Diether Lambrechts, Thomas Van Brussel, et al.. (2018). Fibroblast Growth Factor Receptor-2 Polymorphism rs2981582 is Correlated With Progression-free Survival and Overall Survival in Patients With Metastatic Clear-cell Renal Cell Carcinoma Treated With Sunitinib. Clinical Genitourinary Cancer. 17(2). e235–e246. 4 indexed citations
17.
Verbiest, Annelies, Gabrielle Couchy, Sylvie Job, et al.. (2017). Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated With Outcome During Pazopanib Therapy in the Metastatic Setting. Clinical Genitourinary Cancer. 16(3). e605–e612. 38 indexed citations
18.
19.
Cann, Thomas Van, Annelies Verbiest, Paul Clement, et al.. (2017). Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors. Supportive Care in Cancer. 26(3). 869–878. 42 indexed citations
20.
Verbiest, Annelies, Jacques Pirenne, & Daan Dierickx. (2014). De novo thrombotic microangiopathy after non-renal solid organ transplantation. Blood Reviews. 28(6). 269–279. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.-L. Lee Breakdown of academic impact, for papers by Fawaz Almutairi Breakdown of academic impact, for papers by Gilles Quéré Breakdown of academic impact, for papers by Butuo Li Breakdown of academic impact, for papers by Jian-ying Ma Breakdown of academic impact, for papers by Osvaldo Arén Frontera Breakdown of academic impact, for papers by L.L. Siu Breakdown of academic impact, for papers by Öznur Bal Breakdown of academic impact, for papers by Craig Vargo Breakdown of academic impact, for papers by S.A. Loening
Rankless by CCL
2026